SafeTraces
Financials
Estimates*
USD | 2020 | 2021 | 2023 |
---|---|---|---|
Revenues | 1.1m | 1.4m | 1.3m |
% growth | - | 29 % | - |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
* | $150k | Grant | |
$1.5m | Seed | ||
$6.5m | Series A | ||
* | $10.0m | Series A | |
N/A | N/A | Series A | |
N/A | Debt | ||
Total Funding | €16.5m |
Related Content
Recent News about SafeTraces
EditSafeTraces operates in the safety and environmental health sector, focusing on ensuring the highest safety standards for air quality in buildings. The company serves property managers, facility operators, and large corporations, particularly those in high-risk environments such as tech companies and healthcare facilities. SafeTraces' core product, veriDART, uses airborne tracers to mimic the movement of pathogens like SARS-CoV-2, allowing for accurate verification of safe airflow and identification of high-risk transmission vectors. This technology helps clients target remediation actions and instill public trust in building safety. SafeTraces generates revenue through the sale and deployment of its veriDART solution, as well as consulting services for risk assessment and building safety strategies. The company operates in a market that includes building safety, environmental health, and pandemic response solutions.
Keywords: airborne tracers, building safety, airflow verification, pathogen mobility, SARS-CoV-2, risk assessment, remediation actions, facility operators, environmental health, pandemic response.